These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3940687)

  • 1. Dyslipoproteinemias and manifestations of coronary heart disease. The Lipid Research Clinics Program Prevalence Study.
    Rubenstein C; Romhilt D; Segal P; Heiss G; Chambless LE; Boyle KE; Ekelund LG; Adolph R; Sheffield LT
    Circulation; 1986 Jan; 73(1 Pt 2):I91-9. PubMed ID: 3940687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study.
    Segal P; Insull W; Chambless LE; Stinnett S; LaRosa JC; Weissfeld L; Halfon S; Kwiterovitch PO; Little JA
    Circulation; 1986 Jan; 73(1 Pt 2):I108-18. PubMed ID: 3940677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and clustering of nonlipid coronary risk factors in dyslipoproteinemia. The Lipid Research Clinics Program Prevalence Study.
    Criqui MH; Cowan LD; Heiss G; Haskell WL; Laskarzewski PM; Chambless LE
    Circulation; 1986 Jan; 73(1 Pt 2):I40-50. PubMed ID: 3940683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Customary diet, anthropometry, and dyslipoproteinemia in selected North American populations. The Lipid Research Clinics Program Prevalence Study.
    Little JA; Graves K; Suchindran CM; Milner J; McGuire V; Beaton G; Feather T; Mattson FH; Christiansen D; Williams OD
    Circulation; 1986 Jan; 73(1 Pt 2):I80-90. PubMed ID: 3940686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association of dyslipoproteinemia with symptoms and signs of peripheral arterial disease. The Lipid Research Clinics Program Prevalence Study.
    Pomrehn P; Duncan B; Weissfeld L; Wallace RB; Barnes R; Heiss G; Ekelund LG; Criqui MH; Johnson N; Chambless LE
    Circulation; 1986 Jan; 73(1 Pt 2):I100-7. PubMed ID: 3940676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipid screening to identify high-risk individuals for coronary death. The results of the Lipid Research Clinics prevalence cohort.
    Grover SA; Palmer CS; Coupal L
    Arch Intern Med; 1994 Mar; 154(6):679-84. PubMed ID: 8129502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strenuous physical activity, treadmill exercise test performance and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study.
    Haskell WL; Taylor HL; Wood PD; Schrott H; Heiss G
    Circulation; 1980 Nov; 62(4 Pt 2):IV53-61. PubMed ID: 7418144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group.
    MacLean DR; Petrasovits A; Connelly PW; Joffres M; O'Connor B; Little JA
    Can J Cardiol; 1999 Apr; 15(4):434-44. PubMed ID: 10322253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks.
    Onat A; Can G; Ayhan E; Kaya Z; Hergenç G
    Metabolism; 2009 Oct; 58(10):1393-9. PubMed ID: 19570555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Apr; 117(4):511-5. PubMed ID: 15109440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
    Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
    Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
    Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
    Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apparent protective effect of high density lipoprotein against coronary heart disease in the elderly].
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):827-31. PubMed ID: 12895332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease.
    Hergenç G; Onat A; Sari I; Yazici M; Eryonucu B; Can G
    Angiology; 2008; 59(1):26-35. PubMed ID: 18319219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet and waist-to-hip ratio: important predictors of lipoprotein levels in sedentary and active young men with no evidence of cardiovascular disease.
    Mansfield E; McPherson R; Koski KG
    J Am Diet Assoc; 1999 Nov; 99(11):1373-9. PubMed ID: 10570674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of dyslipoproteinemia with the use of plasma total cholesterol and triglyceride as screening tests. The Lipid Research Clinics Program Prevalence Study.
    Kwiterovich PO; Stewart P; Probstfield JL; Stinnett S; Chambless LE; Chase GA; Jacobs DR; Morrison JA
    Circulation; 1986 Jan; 73(1 Pt 2):I30-9. PubMed ID: 3940681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
    Kim SH; Chunawala L; Linde R; Reaven GM
    J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group.
    Connelly PW; Stachenko S; MacLean DR; Petrasovits A; Little JA
    Can J Cardiol; 1999 Apr; 15(4):419-27. PubMed ID: 10322251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.